Mail & Guardian
Mail & Guardian
hiv jablatest news & developments
South African scientists have released the findings of the first HIV cure trial in Africa with promising results showing viral suppression in 20% of women who stopped taking antiretroviral therapy (ART) after 18 months (Yolanda Mdzeke/Bhekisisa)
HIV JAB

Slash the price of anti-HIV jab by three-quarters, says government

The health department says ViiV Healthcare’s nonprofit price for its anti-HIV jab, CAB-LA, is four times what it can pay

  • Mia Malan
10 min read